Liver Disease in Type 2 Diabetes – Lessons from the Edinburgh Type 2 Diabetes Study Read more about Liver Disease in Type 2 Diabetes – Lessons from the Edinburgh Type 2 Diabetes Study
The Assessment of Small Fibre Neuropathy in Conditions Associated with Neuropathy Read more about The Assessment of Small Fibre Neuropathy in Conditions Associated with Neuropathy
This house believes that incretin based therapies should continue to be used for people with type 2 diabetes Read more about This house believes that incretin based therapies should continue to be used for people with type 2 diabetes
Supporting Primary Care outside of an Out patient based system Read more about Supporting Primary Care outside of an Out patient based system
Closed loop systems in diabetes – how close to routine clinical use? Read more about Closed loop systems in diabetes – how close to routine clinical use?
Endocrine hypertension molecules and genes Read more about Endocrine hypertension molecules and genes
1-year outcomes of REVISE-Diabesity clinical trial Read more about 1-year outcomes of REVISE-Diabesity clinical trial
Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, pioglitazone and empagliflozin (and liraglutide?) Read more about Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, pioglitazone and empagliflozin (and liraglutide?)
